XML 43 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2012
Schedule Of Income Tax (Expense) Benefit
Income tax (expense) benefit for the periods presented consisted of the following:

 

     Years Ended December 31,  
         2012         2011      2010  

Current:

       

Federal

   $ (7   $ 4,309       $ (5,012

State

     —         22         3,440   
  

 

 

   

 

 

    

 

 

 

Total current

     (7     4,331         (1,572

Deferred:

       

Federal

     —          —           —     

State

     —          —           —     
  

 

 

   

 

 

    

 

 

 

Total deferred

     —          —           —     
  

 

 

   

 

 

    

 

 

 

Total income tax (expense) benefit

   $ (7   $ 4,331       $ (1,572
  

 

 

   

 

 

    

 

 

 
Schedule Of Reconciliation Of Statutory Federal Income Tax Rate

A reconciliation of the statutory Federal income tax rate of 35% to the Company’s effective income tax rates is as follows:

 

     Years Ended December 31,  
     2012     2011     2010  

Federal tax provision at statutory rate

     35.00     35.00     35.00

State taxes (net of Federal benefit)

     10.81     2.27     (4.17 %) 

Change in tax reserve

     (0.06 %)      (0.94 %)      (1.84 %) 

Orphan drug credit

     0.25     (0.70 %)      (1.06 %) 

Stock-based compensation

     1.50     0.06     (2.03 %) 

Non-deductible stock-based compensation

     (1.86 %)      0.20     (0.98 %) 

Change in valuation allowance

     (45.48 %)      (29.94 %)      (39.65 %) 

Research and development credits

     —          7.05     9.72

Net proceeds from stockholder securities law settlement

     —          (2.43 %)      —     

Other

     (0.19 %)      (0.53 %)      0.17
  

 

 

   

 

 

   

 

 

 

Benefit (provision) for taxes

     (0.03 )%      10.04     (4.84 %) 
  

 

 

   

 

 

   

 

 

 
Schedule Of Company's Deferred Tax Assets
Significant components of the Company’s deferred tax assets for Federal and state income taxes are follows:

 

     December 31,  
     2012     2011  

Deferred tax assets:

    

Deferred revenue

   $ 15,491      $ 54,116   

Net operating loss carry forward

     72,232        30,767   

Stock-based compensation

     12,721        9,872   

Research and development credits

     13,897        11,280   

Depreciation, amortization and other

     109        133   

Accruals and reserves

     6,530        552   
  

 

 

   

 

 

 

Total deferred tax assets

     120,980        106,720   

Less: valuation allowance

     (98,671     (106,720
  

 

 

   

 

 

 

Total net deferred tax assets

     22,309        —     
  

 

 

   

 

 

 

Deferred tax liabilities

    

Convertible Notes

     (22,309     —     
  

 

 

   

 

 

 

Total deferred tax liabilities

     (22,309     —     
  

 

 

   

 

 

 

Net deferred tax assets

   $ —        $ —     
  

 

 

   

 

 

 

Recorded as:

    

Net current deferred tax assets (included in “Prepaid expenses and other current assets”)

   $ 3,800      $ —     

Net non-current deferred tax assets

     —          —     

Net current deferred tax liabilities

     —          —     

Net non-current deferred tax liabilities (included in “Other non-current liabilities”)

     (3,800     —     
  

 

 

   

 

 

 

Net deferred tax assets

   $ —        $ —     
  

 

 

   

 

 

 
Schedule Of Gross Unrecognized Tax Positions

The following table summarizes activity related to the Company’s gross unrecognized tax positions:

 

     December 31,  
     2012     2011     2010  

Balance as of beginning of year

   $ 3,936      $ 4,128      $ 889   

Additions based on tax positions related to the current year

     400        500        393   

Additions based on tax position related to prior year

     270        109        2,846   

Decreases based on tax positions related to prior year

     (4     (801 )     —     
  

 

 

   

 

 

   

 

 

 

Balance as of end of year

   $ 4,602      $ 3,936      $ 4,128